The main office of represented VC is situated in the Beijing. The fund was located in Asia if to be more exact in China.
We can highlight the next thriving fund investment areas, such as Internet, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight 7LeKang (7lk), QuantiHealth, Percutek Therapeutics.
The important activity for fund was in 2015. The fund is generally included in less than 2 deals every year. Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the General Technology Venture Capital, startups are often financed by ZTE, ShenZhen GTJA Investment Group, Infinity Development Group. The meaningful sponsors for the fund in investment in the same round are ZGC Group, Shanghai Creation Investment, SND Ventures Group. In the next rounds fund is usually obtained by ZGC Group, Shanghai Creation Investment, Proxima Ventures Ltd.
Related Funds
Fund Name | Location |
Artemis Capital Partners | Boston, Massachusetts, United States |
Cascadia Capital | Seattle, United States, Washington |
CfC Stanbic Bank | Kenya, Nairobi, Nairobi Area |
China Merchants Innovation Investment Management | - |
Chongqing New North Zone Government Investment Fund | China, Chongqing, Chongqing Shi |
Chuling Chuangtou | China, Hangzhou, Zhejiang |
Euronext | Amsterdam, Noord-Holland, The Netherlands |
Golden Section Ventures, LLC | Houston, Texas, United States |
Gulf Islamic Investments LLC (GII) | Dubai, United Arab Emirates |
Lianchuang Xingsheng (Beijing) Investment | Beijing, Beijing, China |
LVP | England, London, United Kingdom |
Mark VC | Bellaire, Texas, United States |
Myant Capital Partners | - |
Pithia | Seattle, United States, Washington |
Regiment Capital | Boston, Massachusetts, United States |
VYL LLC | Brooklyn, New York, United States |
Yao Capital | China, Shanghai |
YMC Investment | China, Hangzhou, Zhejiang |
Zhuhai Gaoxin Chuangye Touzi Co., Ltd. | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Eplus 3d | 25 May 2023 | Hangzhou, Zhejiang, China | |||
Suzhou Kerun New Materials | $37M | 31 Jan 2023 | Suzhou, Jiangsu, China | ||
MeetFuture China | $4M | 28 Feb 2022 | Shanghai, Shanghai, China | ||
Cygnus Biosciences | $19M | 14 Nov 2017 | Changping District, Beijing, China | ||
$463K | 29 Nov 2016 | Haidian District, Beijing, China | |||
MemBlaze | 21 Dec 2015 | Dongcheng District, Beijing, China | |||
QuantiHealth | $3M | 12 Oct 2015 | China, Beijing | ||
Cygnus Biosciences | 28 Aug 2015 | China, Beijing |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Eplus 3d | 25 May 2023 | Hangzhou, Zhejiang, China | |||
Suzhou Kerun New Materials | $37M | 31 Jan 2023 | Suzhou, Jiangsu, China | ||
MeetFuture China | $4M | 28 Feb 2022 | Shanghai, Shanghai, China | ||
Cygnus Biosciences | $19M | 14 Nov 2017 | Changping District, Beijing, China | ||
$463K | 29 Nov 2016 | Haidian District, Beijing, China | |||
MemBlaze | 21 Dec 2015 | Dongcheng District, Beijing, China | |||
QuantiHealth | $3M | 12 Oct 2015 | China, Beijing | ||
Cygnus Biosciences | 28 Aug 2015 | China, Beijing |